Breaking News Instant updates and real-time market news.

INSM

Insmed

$24.38

-1.81 (-6.91%)

06:55
08/07/18
08/07
06:55
08/07/18
06:55

Insmed trading halted, news pending

  • 07

    Aug

  • 28

    Sep

INSM Insmed
$24.38

-1.81 (-6.91%)

07/23/18
GSCO
07/23/18
INITIATION
Target $32
GSCO
Neutral
Insmed initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Dana Flanders started Insmed with a Neutral rating and $32 price target. The analyst is taking a more conservative stance on the initial launch of Alis relative to consensus estimates. Flanders does, however, see a high unmet need in treating nontuberculous mycobacterial lung disease.
08/03/18
HCWC
08/03/18
NO CHANGE
Target $35
HCWC
Buy
H.C. Wainwright bullish on Insmed into Tuesday's FDA panel
H.C. Wainwright analyst Andrew Fein is bullish on shares of Insmed into Tuesday's FDA panel meeting. The collective strength of the Amikacin Liposome Inhalation Suspension data "essentially removes the regulatory risks," Fein tells investors in a research note. With no effective treatment available, the analyst expects a positive panel vote. He reiterates a Buy rating on Insmed with a $35 price target. The analyst adds that if he were to assume a 100% probability of success for ALIS, he "could easily justify" a valuation north of $50 per share.
08/06/18
JMPS
08/06/18
DOWNGRADE
JMPS
Market Perform
Insmed downgraded to Market Perform from Outperform at JMP Securities
08/06/18
08/06/18
DOWNGRADE

Market Perform
Insmed downgraded to Market Perform ahead of AdComm vote at JMP Securities
As previously reported, JMP Securities analyst Liisa Bayko downgraded Insmed to Market Perform from Outperform as she has less confidence in Amikacin Liposome Inhalation Suspension after hosting a call last week with Dr. Lee Simon, an ex-FDA Division Director, who confirmed some concerns she had and "pointed out a few new insights" that left Bayko feeling more cautious. Following her call with the regulatory expert, and ahead of the FDA Advisory Committee meeting on Tuesday, Bayko lowered her odds on the probability of success for ALIS to 60% from 80%.

TODAY'S FREE FLY STORIES

PCG

PG&E

$19.62

-6.04 (-23.54%)

12:00
11/15/18
11/15
12:00
11/15/18
12:00
Hot Stocks
PG&E falls -23.2% »

PG&E is down -23.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$132.90

-119.38 (-47.32%)

12:00
11/15/18
11/15
12:00
11/15/18
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -47.8% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYB

RYB Education

$7.38

-9.43 (-56.10%)

12:00
11/15/18
11/15
12:00
11/15/18
12:00
Hot Stocks
RYB Education falls -54.5% »

RYB Education is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWCH

Switch

$7.98

0.91 (12.87%)

12:00
11/15/18
11/15
12:00
11/15/18
12:00
Hot Stocks
Switch rises 12.9% »

Switch is up 12.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFS

Smart & Final Stores

$6.45

1.49 (30.04%)

12:00
11/15/18
11/15
12:00
11/15/18
12:00
Hot Stocks
Smart & Final Stores rises 29.9% »

Smart & Final Stores…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$4.22

1.35 (47.04%)

12:00
11/15/18
11/15
12:00
11/15/18
12:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN rises 47.6% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MO

Altria Group

$58.47

-0.62 (-1.05%)

, PM

Philip Morris

$85.34

-0.17 (-0.20%)

11:58
11/15/18
11/15
11:58
11/15/18
11:58
Hot Stocks
Altria Group issues statement on FDA proposed new steps against underage smoking »

Murray Garnick, Executive…

MO

Altria Group

$58.47

-0.62 (-1.05%)

PM

Philip Morris

$85.34

-0.17 (-0.20%)

BTI

British American Tobacco

$35.69

-0.82 (-2.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDW

Tidewater

$24.98

0.49 (2.00%)

, GLF

GulfMark Offshore

$27.62

0.75 (2.79%)

11:55
11/15/18
11/15
11:55
11/15/18
11:55
Hot Stocks
Tidewater announces completion of business combination with GulfMark »

Tidewater (TDW) announced…

TDW

Tidewater

$24.98

0.49 (2.00%)

GLF

GulfMark Offshore

$27.62

0.75 (2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSBC

HSBC

$41.91

0.15 (0.36%)

11:55
11/15/18
11/15
11:55
11/15/18
11:55
Options
HSBC put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
11/15/18
11/15
11:55
11/15/18
11:55
Conference/Events
RBC Capital telecom/data centers analyst to hold a group luncheon »

Telecom & Data…

QLYS

Qualys

$72.81

0.89 (1.24%)

11:55
11/15/18
11/15
11:55
11/15/18
11:55
Conference/Events
Qualys to hold analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 09

    Jan

11:55
11/15/18
11/15
11:55
11/15/18
11:55
Conference/Events
RBC Capital U.S. Internet analyst to hold a group luncheon »

U.S. Internet Analyst…

PRSP

Perspecta

$21.53

-0.8 (-3.58%)

11:54
11/15/18
11/15
11:54
11/15/18
11:54
Hot Stocks
Perspecta in partnership with Abaco Systems for 1553 Bus Defender product »

Perspecta announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CB

Chubb

$128.87

2.18 (1.72%)

11:49
11/15/18
11/15
11:49
11/15/18
11:49
Hot Stocks
Chubb board authorizes $1.5B share repurchase program »

Chubb's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COG

Cabot Oil & Gas

$25.55

-0.28 (-1.08%)

11:45
11/15/18
11/15
11:45
11/15/18
11:45
Options
Cabot Oil & Gas call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

11:45
11/15/18
11/15
11:45
11/15/18
11:45
General news
U.S. blue chips remain under pressure »

U.S. blue chips remain…

PM

Philip Morris

$84.99

-0.52 (-0.61%)

, BTI

British American Tobacco

$35.46

-1.05 (-2.88%)

11:41
11/15/18
11/15
11:41
11/15/18
11:41
Hot Stocks
FDA proposes steps to prevent flavored tobacco access, ban menthol cigarettes »

FDA Commissioner Scott…

PM

Philip Morris

$84.99

-0.52 (-0.61%)

BTI

British American Tobacco

$35.46

-1.05 (-2.88%)

MO

Altria Group

$58.38

-0.71 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDR

McDermott

$8.25

0.36 (4.56%)

11:35
11/15/18
11/15
11:35
11/15/18
11:35
Options
McDermott put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LXFT

Luxoft

$35.44

-3.3 (-8.52%)

11:33
11/15/18
11/15
11:33
11/15/18
11:33
Downgrade
Luxoft rating change  »

Luxoft downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TDY

Teledyne

$221.27

1.165 (0.53%)

11:31
11/15/18
11/15
11:31
11/15/18
11:31
Hot Stocks
Teledyne awarded $7.51M Navy contract »

Teledyne Microwave…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:30
11/15/18
11/15
11:30
11/15/18
11:30
Conference/Events
Leerink healthcare analysts to hold an analyst/industry conference call »

Analysts discuss the U.S.…

MDU

MDU Resources

$25.86

-0.265 (-1.01%)

11:30
11/15/18
11/15
11:30
11/15/18
11:30
Hot Stocks
MDU Resources increases quarterly dividend »

The MDU Resources Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$199.90

-2.53 (-1.25%)

11:29
11/15/18
11/15
11:29
11/15/18
11:29
Periodicals
Goldman Sachs CEO 'outraged' by 1MDB scandal, Bloomberg reports »

Goldman Sachs CEO David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$78.25

-0.65 (-0.82%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Options
XPO Logistics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$32.50

-1.2 (-3.56%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
Biohaven Pharmaceutical management to meet with Morgan Stanley »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.